Loading
Latest filing published 05 Jun 2026 for XSpray Pharma AB (publ), €45k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Anders Lennart Bladh on record concern XSpray Pharma AB (publ). We count 4 filings, every one of them for a trade on 3 June 2026.
In open-market terms, that means 2 purchases worth €90k on one side and 2 sales worth €90k on the other. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 5 June 2026, reports an open-market purchase of €45k in XSpray Pharma AB (publ). Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration